Does DARATUMUMAB Cause Skin lesion? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Skin lesion have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.0% of all adverse event reports for DARATUMUMAB.
12
Reports of Skin lesion with DARATUMUMAB
0.0%
of all DARATUMUMAB reports
3
Deaths
3
Hospitalizations
How Dangerous Is Skin lesion From DARATUMUMAB?
Of the 12 reports, 3 (25.0%) resulted in death, 3 (25.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Skin lesion Listed in the Official Label?
Yes, Skin lesion is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Skin lesion?
SECUKINUMAB (1,909)
ADALIMUMAB (1,507)
METHOTREXATE (1,237)
DUPILUMAB (685)
ETANERCEPT (647)
PREDNISONE (617)
TOFACITINIB (478)
INFLIXIMAB (474)
CYCLOSPORINE (380)
LENALIDOMIDE (369)
Which DARATUMUMAB Alternatives Have Lower Skin lesion Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE